182400 — NKMax Co Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeSmall Cap
- KR₩167bn
- KR₩219bn
- KR₩11bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 12,722 | 36,070 | 20,760 | 15,018 | 662 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,464 | 4,370 | 4,117 | 3,675 | 5,843 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 22,201 | 47,017 | 29,838 | 24,903 | 11,800 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 31,382 | 33,461 | 32,842 | 30,738 | 8,450 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 182,159 | 205,308 | 180,601 | 169,695 | 184,389 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 52,298 | 48,163 | 42,669 | 71,193 | 59,279 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 74,646 | 85,483 | 60,338 | 83,775 | 72,307 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 107,513 | 119,824 | 120,262 | 85,920 | 112,082 |
Total Liabilities & Shareholders' Equity | 182,159 | 205,308 | 180,601 | 169,695 | 184,389 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |